#AI in drug discovery has incredible potential, but it remains hard and some of the hype may not be grounded in reality. Our CEO and founder @DaphneKoller spoke with @MaxGelman about why she believes the industry needs to calibrate people's expectations with what's possible. Endpoints News (@endpts) Despite a flood of companies entering the AI space, the field has little hard data to show for itself, at least as far as the public can see. And that begs the question: How much of the “AI revolution” is hype, and how much is grounded in reality? endpts.com/biopharma-has-hyp… — https://nitter.net/endpts/status/1496171266667073547#m

→ View original post on X — @daphnekoller, 2022-02-23 22:18 UTC